Polyclonal Rabbit anti‑Human VAMP3 / VAMP‑3 Antibody (N‑Terminus, IF, WB) LS‑C153390
Polyclonal Rabbit anti‑Human VAMP3 / VAMP‑3 Antibody (N‑Terminus, IF, WB) LS‑C153390
Antibody:
VAMP3 / VAMP-3 Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
VAMP3 / VAMP-3 Rabbit anti-Human Polyclonal (N-Terminus) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
VAMP-3 antibody LS-C153390 is an unconjugated rabbit polyclonal antibody to human VAMP-3 (VAMP3) (N-Terminus). Validated for ELISA, IF and WB.
Target
Human VAMP3 / VAMP-3
Synonyms
VAMP3 | Cellubrevin | Synaptobrevin-3 | VAMP-3 | CEB | SYB3
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A purified
Immunogen
Synthetic peptide derived from N-term domain of the human cellubrevin protein.
Specificity
Reacts with human 10 kD VAMP-3 of CaCo-2 cell extract. No cross reactivity with cellubrevin from other species (canine, rat).
Applications
- Immunofluorescence
- Western blot
- ELISA
Presentation
100 mM Tris-glycine, 2% sucrose
Reconstitution
100 µl Distilled water
Storage
Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at 4°C. For extended periods store in aliquots at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, Western blot, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Rat
Applications:
Immunofluorescence, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot
Source:
E. coli
Tag:
None
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/24/2024